Rensselaer, NY

Curia – Rensselaer, NY, USA

Highly potent and controlled API manufacturing, from lab scale to roughly 180,000 L of commercial capacity.

Curia’s Rensselaer facility develops and manufactures highly potent and controlled active pharmaceutical ingredients from lab scale to large scale. With Schedule I-V licensing, containment awarded SafeBridge’s “Industry Standard” designation in 2025, and a $50 million capacity expansion featuring a fully automated suite, Rensselaer anchors Curia’s US commercial API network.

Facility at a glance

Expertise

270+ experts

A deep technical and operations team supporting development, scale-up and commercial API manufacture.

Total capacity

~180,000 L

Approximately 180,000 L of total reactor volume across the site.

Scale range

200 to 8,000 L

Reactor capacity from 200 to 8,000 L carries programs from pilot to commercial scale.

Site investment

$50M expansion

A $50 million capacity expansion adds a fully automated manufacturing suite.

Sustainability

Cleaner air emissions

An on-site thermal oxidizer converts volatile organic compounds and hazardous air pollutants into carbon dioxide and water.

Download

Rensselaer site capabilities overview

What this site does

Licensed for Schedule I-V compounds

Rensselaer is licensed for Schedule I-V controlled substances, including analytical testing and DEA-approved storage, giving sponsors a single regulated site for development, manufacture and handling of scheduled molecules.

HPAPI production from grams to 120 kg

The site produces highly potent compounds from gram quantities to 120 kg batches, with containment practices awarded the “Industry Standard” designation by SafeBridge in 2025.

Engineering safety into every process

Dedicated process safety capabilities, including process review, safety data gathering and process modification, ensure operations meet regulations before chemistry reaches the plant floor.

40+ commercial products and a late-phase pipeline

Rensselaer manufactures more than 40 commercial products alongside 20+ Phase II and III products, taking processes from development through validation to routine commercial supply.

From development to large-scale manufacturing

With reactor capacity from 200 to 8,000 L and roughly 180,000 L of total volume, the site scales processes from pilot through commercial campaigns.

Air emissions treated on site

A thermal oxidizer converts volatile organic compounds and hazardous air pollutants from manufacturing into carbon dioxide and water, reducing the site’s air emissions from large-scale API production.

Why clients love this site

Highly potent compound production

SafeBridge Consultants awarded Rensselaer’s highly potent compound production their “Industry Standard” designation in 2025.

Proven commercial depth

More than 40 commercial products and 20+ Phase II and III products are manufactured at the site today.

Controlled substances without compromise

Schedule I-V licensing with DEA-approved storage and on-site analytical keeps regulated programs on one site.

Investment in future capacity

A $50 million expansion with a fully automated suite adds capacity that is ready when your program needs it.

How this site fits into Curia’s network

Albany, NY – Development and analytical hub

Albany develops processes phase-appropriately from preclinical through Phase II/III and houses Curia’s consolidated analytical center, feeding programs into Rensselaer for commercial-scale and high-potency manufacture.

Springfield, MO – Large-scale controlled substances

Springfield complements Rensselaer with Schedule I-V manufacturing at gram to metric ton scales, plus large-scale organometallic, cryogenic and fractional distillation capabilities.

Learn More

Valladolid, Spain – High potency and sterile API in Europe

Valladolid extends Curia’s high-potency network with OEB1-5 facilities, isolator technology and aseptic API sterilization, giving global programs a European counterpart to Rensselaer’s US capacity.

Learn More

Frankfurt, Germany – Regulatory starting materials and fine chemicals

Frankfurt supplies quick scale-up and manufacture of complex regulatory starting materials and fine chemicals, supporting the upstream supply chain for Rensselaer’s commercial API programs.

Learn More